MAPT and early-onset autosomal dominant Alzheimer disease: There is a possibility that the tau PET tracer used (Flortaucipir) may have been binding to different tau isoforms or other pathologies,21,22 in which case this group may be better explained as an alternate pathologic process separable from Alzheimer’s disease, or otherwise as an atypical Alzheimer’s disease variant.